Qube Research & Technologies (QRT)’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-84,178
Closed -$1.4M 3817
2024
Q1
$1.4M Hold
84,178
﹤0.01% 1946
2023
Q4
$1.26M Buy
84,178
+21,588
+34% +$314K ﹤0.01% 1796
2023
Q3
$907K Buy
62,590
+17,207
+38% +$257K ﹤0.01% 1777
2023
Q2
$692K Buy
45,383
+11,348
+33% +$170K ﹤0.01% 1428
2023
Q1
$515K Buy
34,035
+16,828
+98% +$249K ﹤0.01% 1559
2022
Q4
$239K Buy
+17,207
New +$243K ﹤0.01% 1736

Other funds holding BCAT

Qube Research & Technologies (QRT)'s BCAT Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2024, closing a stake of 84,178 shares — an estimated $1.4M sold.

Qube Research & Technologies (QRT) first reported a position in BCAT in Q4 2022 and held it in 6 quarters. The position peaked at $1.4M in Q1 2024. 86 funds tracked by Wall St. Rank hold BCAT as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 84,178 BlackRock Capital Allocation Term Trust shares in Q2 2024, an estimated $1.4M.
  • Qube Research & Technologies (QRT) first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s BlackRock Capital Allocation Term Trust position peaked at $1.4M in Q1 2024.
  • 86 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.